76 related articles for article (PubMed ID: 23966609)
1. A cross-sectional study of associations between nonsynonymous mutations of the BARD1 gene and breast cancer in Han Chinese women.
Liu H; Zhang H; Sun X; He Y; Li J; Guo X
Asia Pac J Public Health; 2013 Jul; 25(4 Suppl):8S-14S. PubMed ID: 23966609
[TBL] [Abstract][Full Text] [Related]
2. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
3. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis.
Huo X; Hu Z; Zhai X; Wang Y; Wang S; Wang X; Qin J; Chen W; Jin G; Liu J; Gao J; Wei Q; Wang X; Shen H
Breast Cancer Res Treat; 2007 May; 102(3):329-37. PubMed ID: 17028982
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis.
Zhou X; Han S; Wang S; Chen X; Dong J; Shi X; Xia Y; Wang X; Hu Z; Shen H
Gynecol Oncol; 2009 Aug; 114(2):327-31. PubMed ID: 19482343
[TBL] [Abstract][Full Text] [Related]
5. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
[TBL] [Abstract][Full Text] [Related]
6. Association of BARD1 and BRIP1 Gene Polymorphisms with the Risk of Uveal Melanoma.
Mukhana L; Aissa AA; Ahmed AAM; Saakyan SV; Tsygankov AY; Blagonravov ML; Azova MM
Bull Exp Biol Med; 2023 Jul; 175(3):399-403. PubMed ID: 37561379
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of BARD1 in familial breast cancer patients in Japan.
Ishitobi M; Miyoshi Y; Hasegawa S; Egawa C; Tamaki Y; Monden M; Noguchi S
Cancer Lett; 2003 Oct; 200(1):1-7. PubMed ID: 14550946
[TBL] [Abstract][Full Text] [Related]
8. [Association between single nucleotide polymorphism of BARD1 gene and BRCA1 gene mutation in epithelial ovarian cancer].
Liu WL; Zhao JZ; Wang ZZ; Dong B; Hou YY; Wu XX; Guo YJ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):403-410. PubMed ID: 28647964
[No Abstract] [Full Text] [Related]
9. BARD1 and breast cancer in Poland.
Jakubowska A; Cybulski C; Szymańska A; Huzarski T; Byrski T; Gronwald J; Debniak T; Górski B; Kowalska E; Narod SA; Lubiński J
Breast Cancer Res Treat; 2008 Jan; 107(1):119-22. PubMed ID: 17333333
[TBL] [Abstract][Full Text] [Related]
10. Mutations in exon region of BRCA1-related RING domain 1 gene and risk of breast cancer.
Wu J; Aini A; Ma B
Mol Genet Genomic Med; 2022 Mar; 10(3):e1847. PubMed ID: 35084806
[TBL] [Abstract][Full Text] [Related]
11. The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population.
Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Carrera I; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Santos JL; Jara L
Mol Biol Rep; 2012 Aug; 39(8):8091-8. PubMed ID: 22544576
[TBL] [Abstract][Full Text] [Related]
12. The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis.
Johnatty SE; Beesley J; Chen X; Hopper JL; Southey MC; Giles GG; Goldgar DE; Chenevix-Trench G; Spurdle AB; ;
Breast Cancer Res Treat; 2009 May; 115(1):145-50. PubMed ID: 18481171
[TBL] [Abstract][Full Text] [Related]
13. Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families.
De Brakeleer S; De Grève J; Loris R; Janin N; Lissens W; Sermijn E; Teugels E
Hum Mutat; 2010 Mar; 31(3):E1175-85. PubMed ID: 20077502
[TBL] [Abstract][Full Text] [Related]
14. BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer.
Gorringe KL; Choong DY; Visvader JE; Lindeman GJ; Campbell IG
Breast Cancer Res Treat; 2008 Oct; 111(3):505-9. PubMed ID: 17972171
[TBL] [Abstract][Full Text] [Related]
15. BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition.
Vahteristo P; Syrjäkoski K; Heikkinen T; Eerola H; Aittomäki K; von Smitten K; Holli K; Blomqvist C; Kallioniemi OP; Nevanlinna H
Eur J Hum Genet; 2006 Feb; 14(2):167-72. PubMed ID: 16333312
[TBL] [Abstract][Full Text] [Related]
16. BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility.
Fu W; Zhu J; Xiong SW; Jia W; Zhao Z; Zhu SB; Hu JH; Wang FH; Xia H; He J; Liu GC
EBioMedicine; 2017 Feb; 16():101-105. PubMed ID: 28161399
[TBL] [Abstract][Full Text] [Related]
17. Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
Ratajska M; Antoszewska E; Piskorz A; Brozek I; Borg Å; Kusmierek H; Biernat W; Limon J
Breast Cancer Res Treat; 2012 Jan; 131(1):89-97. PubMed ID: 21344236
[TBL] [Abstract][Full Text] [Related]
18. BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer.
Sabatier R; Adélaïde J; Finetti P; Ferrari A; Huiart L; Sobol H; Chaffanet M; Birnbaum D; Bertucci F
Genes Chromosomes Cancer; 2010 Dec; 49(12):1143-51. PubMed ID: 20842729
[TBL] [Abstract][Full Text] [Related]
19. Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer.
Karppinen SM; Heikkinen K; Rapakko K; Winqvist R
J Med Genet; 2004 Sep; 41(9):e114. PubMed ID: 15342711
[No Abstract] [Full Text] [Related]
20. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M
Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
